Section Introduction: Precision Engineering Meets Patient-Centric Design
Le V1 Injection Pen is a next-generation reusable insulin delivery device engineered for pharmaceutical brands seeking reliability, customization, and regulatory compliance. Designed to accommodate standard 3ml cassette bottles, this metal-body injector offers dual dose capacity options — 60IU (0.6mL) or 80IU (0.8mL) — making it adaptable for both conventional insulin therapy and higher-dose biologics like GLP-1 agonists.
With an injection force of less than 15N, it ensures comfortable administration even for patients with limited hand strength. Backed by CE and FDA-compliant manufacturing processes, the V1 Pen is ready for global export and clinical adoption.
“Low injection force devices improve adherence in elderly and pediatric populations.” — Journal of Diabetes Science and Technology, 2023
Key Features Engineered for Compliance & Comfort
✅ Dual Dose Capacity: 60IU or 80IU
Unlike single-capacity pens, the V1 offers flexibility:
- 60IU Model: Ideal for standard U-100 insulin regimens.
- 80IU Model: Perfect for concentrated insulins (e.g., U-200, U-300) or high-volume biologic therapies.
Both models maintain 0.01mL increments for precise titration.
🎯 Clinical-Grade Accuracy: ±5% Tolerance
Every pen undergoes rigorous calibration to meet international standards:
- Injection Accuracy: ±5% across full dose range (verified per ISO 11608-1)
- Minimum Dose: 0.01mL (1 unit) — critical for pediatric and micro-dosing applications
- Maximum Dose: 0.6mL or 0.8mL depending on model
This level of precision reduces dosing errors and supports better glycemic control outcomes.
💪 Ultra-Low Injection Resistance: <15N
Engineered with optimized spring mechanics and low-friction internal components:
- Requires less than 15 Newtons of force to activate — significantly lower than industry average (~20–25N)
- Reduces patient discomfort and improves compliance, especially among elderly or arthritic users
♻️ Sustainable & Cost-Efficient
As a reusable device, each V1 Pen can be used over 3,000 times, replacing hundreds of disposable injectors — reducing plastic waste and lowering total cost of ownership for healthcare systems.
🖌️ Full Customization for Brand Identity
Stand out in competitive markets with tailored branding:
- Logo Engraving: Laser-etched logo on barrel or cap
- Color Matching: Choose from 5 premium metallic finishes (Red, Gold, Navy Blue, Greener, Grey) or request custom Pantone
- Packaging & IFU: Co-branded boxes, multilingual instructions, QR codes for digital support
Technical Specifications Table
| Paramètres | Spécifications |
|---|---|
| Nom du produit | V1 Reusable Metal Insulin Pen |
| Type of Use | Reusable |
| Compatible Cartridge | Standard 3ml Cassette Bottle (ISO 11608-3 compliant) |
| Dose Options | 60IU (0.6mL) or 80IU (0.8mL) |
| Min. Injection Volume | 0.01 mL |
| Max. Injection Volume | 0.6 mL or 0.8 mL |
| Injection Increments | 0.01 mL (1 unit) |
| Injection Accuracy | ±5% (per ISO 11608-1) |
| Injection Resistance | <15 N |
| Matériau du corps | Anodized Aluminum Alloy + Medical-Grade Plastic |
| Couleurs disponibles | Red, Gold, Navy Blue, Greener, Grey (+ Custom Pantone on Request) |
| Certifications | CE, FDA Registered Facility, ISO 13485 |
| MOQ | 5,000 pcs (Custom Logo); 10,000 pcs (Custom Color) |
Product Structure Diagram Breakdown
(Based on your provided diagram)
- Injection Pen Cap: Protects needle exit; snap-on design for hygiene and portability.
- Refill Holders: Securely locks 3ml cartridge; tool-free replacement mechanism.
- Dosage Window: Clear view of selected dose with large numerals for easy reading.
- Dose Indication Ring: Rotating dial with audible clicks for accurate setting.
- Release Button: Ergonomically positioned for thumb activation; triggers smooth injection.
Why Choose PharGlass as Your OEM Partner?
We don’t just manufacture pens — we co-create branded drug delivery solutions that meet global regulatory expectations and patient needs.
🔹 Regulatory Ready
Full documentation package available: DMF, Material Declaration, Biocompatibility Reports, Sterilization Validation.
🔹 Scalable Production
Annual output >50 million units. Lead time: 45–60 days for customized orders.
🔹 Global Logistics Support
Shipped from Zhengzhou, China with temperature-controlled options, full export docs, and Incoterms flexibility (FOB, CIF, DDP).
🔹 R&D Collaboration
Our engineering team works directly with pharma clients to adapt mechanisms for novel drugs (e.g., viscosity-adjusted springs for biologics).
Ideal Applications
- Insulin Therapy (Type 1 & Type 2 Diabetes)
- GLP-1 Agonists (Semaglutide, Liraglutide, Dulaglutide)
- Growth Hormones (Somatropin)
- Oncology Supportives (Filgrastim, Epoetin)
- Biosimilars & Novel Biologics
Ready to Launch Your Branded Injector?
Don’t settle for generic disposables. Elevate your product with a precision-engineered, reusable metal pen that patients trust and regulators approve.
📩 Contactez-nous dès aujourd'hui for:
- Free sample evaluation (specify 60IU or 80IU model)
- Custom quotation with MOQ breakdown
- Regulatory dossier assistance
- Co-development consultation for novel formulations
FR 
EN 
AR 
DE 
ES 
PT 
FA 
RU